Careers
CONTACT
PRODUCT SIGN IN

Oncology Index

Leverage Industry-Leading Oncology Market Research

  • View Payer Management Behavior in Oncology: Analyze current payer management strategies for specific oncology brands, including prioritization of indications and coverage decisions across plans.
  • Create Payer Profiles from Real-World Insights: Build detailed payer profiles using unblinded responses to uncover management trends, decision-making patterns, and access strategies.
  • Observe Coverage Trends Across Commercial and Medicare Payers: Track anticipated coverage changes over time across key Commercial and Medicare payer organizations to stay ahead of market shifts.
  • Understand Payer and IDN Dynamics in Oncology: Gain insight into the evolving relationships between payers and IDNs to understand how they influence oncology treatment.
ACCESS THE BROCHURE

Stay Ahead of Oncology Market Access Trends

What Our Clients Are Saying

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."

Director, Commercial and Medical IT, Rare Disease

Global Biotech Company

How We Can Help

We deliver quarterly reports that spotlight the latest and emerging access restrictions across targeted oncology therapeutic areas. These comprehensive insights help your team refine both national and regional strategies, transforming directional trends into practical, actionable steps for enhanced market performance.

How can the Oncology Index help my team understand payer behavior and coverage decisions in oncology?

The Oncology Index gives your team clear visibility into how payers manage oncology therapies by revealing coverage policies, restrictions, and decision-making patterns across plans.

The Oncology Index uncovers evolving oncology market dynamics by tracking shifts in coverage, site-of-care preferences, and management of new and emerging therapies.

How can the Oncology Index help inform oncology market access and commercial strategy?

By translating payer behavior and coverage insights into actionable intelligence, the Oncology Index helps inform smarter market access and commercial strategies.

RESOURCES

Key Insights From MMIT

whats-shaping-coverage-under-medicare-drug-price-negotiation

Competition, Not Discounts: What’s Shaping Coverage Under Medicare Drug Price Negotiation

Explore how evolving coverage, oral therapies, generics and new indications are shaping the next phase of the GLP-1 market.

8 minutes

Access Now

how-vertical-integration-rewriting-biosimilar-strategy
Article

How Vertical Integration Is Rewriting Biosimilar Strategy

Explore how vertical integration, contracting and PBM private-label strategies are reshaping biosimilar adoption and market access.

10 minutes

Access Now

novel-moas-new-payer-standard
Article

Immunology at an Inflection Point: Novel MoAs and the New Payer Standard

Explore how novel immunology therapies, biosimilars and payer expectations are reshaping market access and formulary strategy.

10 minutes

Access Now

RELATED SOLUTIONS

Solutions to Support Your Strategy

Enhance the value of the Oncology Index with complementary solutions that offer your team enhanced visibility into payer behaviour, patient pathways, and the uptake of emerging therapies. With this broader perspective, you can translate insight into decisive, well-informed action across the oncology landscape.

Message Monitor

Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.

Learn More

Biologics and Injectables Index

Our Biologics and Injectables Index helps you access therapeutic area specific data about payer management priorities, IDN dynamics, copay programs, and more.

Learn More

P&T Perspectives

P&T Perspectives provides qualitative and tangible feedback through a simulated P&T session that informs your brand’s strategy and helps you determine how your product—or your competitor’s product—will fare in a real P&T Committee review.

Learn More

Rapid Response

Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.

Learn More
Stay In Touch

Be the first to know about new arrivals and promotions

NEW RELEASE: The State of Patient Access 2026

Access the Report